Bloomberg Nursing’s Freida Chavez, Linda McGillis Hall and Kelly Metcalfe were honoured at the U of T Salutes! event on March 6, held to recognize University of Toronto researchers who received international and major national research accolades in 2016. President Meric Gertler spoke proudly of the breadth, depth and diversity of the research excellence at the University.
Dr. Chavez was recognized for her induction as an International Fellow into the American Academy of Nursing.
Dr. Freida Chavez is an Associate Professor at the Lawrence Bloomberg Faculty of Nursing. She holds a prestigious role as Fellow at the World Health Organization Collaborating Centre in Health Promotion at the University of Toronto and serves as a mental health and global health expert for the International Council of Nurses in Geneva, Switzerland. She spearheaded the development of Bloomberg Nursing courses that examine global health issues and has successfully led several of Bloomberg Nursing’s global projects.
Dr. McGillis Hall was recognized for her induction into the Sigma Theta Tau International (STTI) Nurse Research Hall of Fame. Known internationally for her work in nursing health services and systems research, she was inducted into the Hall of Fame in July 2016.
Dr. Linda McGillis Hall is the Kathleen Russell Distinguished Professor and Associate Dean, Research & External Relations at the Lawrence Bloomberg Faculty of Nursing. A recognized leader in nursing health services and systems research, Dr. McGillis Hall’s research focuses on health human resources and the nursing work environment.
Dr. Metcalfe was recognized for her induction as an International Fellow into the American Academy of Nursing.
Dr. Kelly Metcalfe is a Professor at the Lawrence Bloomberg Faculty of Nursing and an Adjunct Scientist at the Familial Breast Cancer Research Institute at the Women’s College Research Institute. Dr. Metcalfe holds the Bloomberg Faculty of Nursing Limited-Term Professor in Cancer Genetics. Her primary area of research is on the prevention and treatment of cancer in individuals at an increased risk of developing the disease.